(Note: The company disclosed in an S-1/A filing dated Aug. 9, 2024, that it changed its name to Industries of the Americas – from Medical Industries of the Americas – in November 2023. In the Aug. 9, 2024, filing – the S-1/A filing – Industries of the Americas also disclosed that it has changed its IPO listing venue to the NYSE – American Stock Exchange – from the NASDAQ,  its original venue.)

Industries of the Americas, Inc. is a U.S.-based industrial company that has acquired, rehabilitated, and validated two factories on a 13.7 acre industrial campus in Alabama. We own a variety of industrial hardware assets that have historically been utilized in manufacturing essential products in the United States. One of these factories has a major piece of natural rubber hardware comprising 100,000 square feet of structure from which we introduced the American Safety Glove, which is the only domestically manufactured natural rubber glove for the industrial markets. The second factory manufactures safety supplies, including cold/hot packs. The forthcoming phase is now planned to push the first two product lines through distribution and sales and roll out of additional products. This includes a potential roll out to 2,200 stores with Tractor Supply, and online through both Amazon and WalMart. We have identified market opportunities to potentially expand our industrial base, methodically competing with Asian imports across product categories on both quality and price, with robust market opportunities and plans for expansion.

We plan to utilize the capital proceeds from this offering for further outfitting our production facilities to increase manufacturing capabilities for historically essential products, including but not limited to: dipped latex products, thermal packs, surgical marking products and disposable scalpels. We own a variety of machinery and equipment capable of producing dipped latex products and thermal packs. With this equipment, we are currently producing industrial grade powdered latex gloves and disposable cold packs. Eventually we plan to produce additional latex products, such as latex exam and surgical gloves and condoms, additional varieties of thermal packs, and eventually surgical marking products and disposable scalpels.

Our equipment includes four latex dip lines and 12 vertical form, fill, and seal machines (“VFFSMs”).

The four latex dip lines are capable of producing lightly powdered industrial natural latex gloves, medical grade latex gloves and condoms. One of the latex dip lines is currently tooled and producing industrial lightly powdered gloves. We are currently in the process of retooling the other three existing condom dip lines to manufacture medical grade powder-free latex gloves. We plan to have these dip lines retooled and producing medical grade latex gloves within approximately six months of the consummation of this offering.

Our manufacturing facility is located in Eufaula, Alabama. The Eufaula facility has direct rail access to the ports of Savannah, Georgia and Mobile, Alabama.

The primary raw material used in our production process for disposable latex gloves and other latex products is raw natural rubber latex. We purchase such material from third-party brokers operating out of the Port of Savannah, which is the site of a major rubber and latex terminal.

The primary raw materials used in our production process of thermal packs are two-ply laminated polyethylene, magnesium sulphate (for hot packs), and urea, an agricultural grade fertilizer (for cold packs). These materials are purchased from suppliers and commodities chemical brokers located in the United States and shipped to our Eufaula facility via truck. Once we have increased production to full scale, we expect to have the capability to receive shipments by rail, utilizing our private, onsite rail spur.

Our immediate focus is on the United States and other North American markets. Our target customers are primarily distributors and wholesalers, with a secondary focus on end users.

**Note: We are a development-stage company that has produced limited revenue to date.

Note: Net loss and revenue are for the 12 months that ended Dec. 31, 2023.

Note: As of September 30, 2023, our only employees are those of the executive team. We have historically scaled to as many as 58 full-time service providers (for example as of September 1, 2022) by utilizing a combination of temporary hires, third-party staffing agency(s), and contract labor. In the previous year, we retained workforce labor to commence production, which continued until a certain threshold of inventory was established. Once a certain threshold of inventory is established, we release all labor to reduce costs. We estimate that, once fully operational, the factory will employ approximately 280 persons. We estimate that we will reach this employment capacity in approximately two years following this offering.

(Note: Industries of the Americas – formerly known as Medical Industries of the Americas – filed an S-1/A dated Aug. 9, 2023, in which it disclosed that the company’s name has been changed; that same filing also disclosed a change in the listing venue to the NYSE – American Exchange from the NASDAQ. No terms have been disclosed yet for the IPO, which has estimated proceeds of $10.0 million. Background: Medical Industries of the Americas filed its S-1 on Feb. 14, 2023.)